Choose the brand aligned with your industry so we can best serve your needs.
For researchers, scientists, and technical professionals: Your one-stop shop for the complete range of laboratory, production, and safety products and services.
Small and Specialty Supplier Partner Small and/or specialty supplier based on Federal laws and SBA requirements. Learn More
Navitoclax-piperazine (ABT-263-piperazine) is an analog of Navitoclax and acts as a BCL-XL inhibitor. It serves as the ligand for the target protein of PROTAC DT2216. This compound, when combined with an E3 ubiquitin ligase VHL ligand, can be used to synthesize PROTAC DT2216. PROTACs are compounds that leverage the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
Analog of Navitoclax
Acts as a BCL-XL inhibitor
Serves as a ligand for target proteins
Can be used in the synthesis of PROTACs
Utilizes the ubiquitin-proteasome system for selective protein degradation
Encompass Procurement Services Non-distribution item offered as a customer accommodation; additional freight charges may apply. Learn More
Small and Specialty Supplier Partner Small and/or specialty supplier based on Federal laws and SBA requirements. Learn More
Piperazin-2-one is a piperazine ring derivative containing amide and ester carbonyl groups. It functions as an important intermediate, facilitating the synthesis of a variety of active compounds. Its derivatives have also demonstrated anti-adenoviral activity.
Can be used for the synthesis of various active compounds.
Derivatives exhibit anti-adenoviral activity.
Encompass Procurement Services Non-distribution item offered as a customer accommodation; additional freight charges may apply. Learn More
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link: eMolecules Building Block Tool
Encompass Procurement Services Non-distribution item offered as a customer accommodation; additional freight charges may apply. Learn More